PMID: 25735359Mar 5, 2015Paper

BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis

Asian Pacific Journal of Cancer Prevention : APJCP
Mohammad Forat-YazdiMortaza Fattahi

Abstract

To date several common mutations in BRCA1 and BRCA2 associated with breast cancer have been reported in different populations. However, the common BRCA1 and BRCA2 mutations among breast cancer patients in Iran have not been described in detail. To comprehensively assess the frequency and distribution of the most common BRCA1 and BRCA2 mutations in Iranian breast cancer patients, we conducted this meta-analysis on 13 relevant published studies indentified in a literature search on PubMed and SID. A total of 11 BRCA1 and BRCA2 distinct common mutations were identified, reported twice or more in the articles, of which 10 (c.2311T>C, c.3113A>G, c.4308T>C, c.4837A>G, c.2612C>T, c.3119G>A, c.3548A>G, c.5213G>A c.IVS16-92A/G, and c.IVS16-68A/G) mutations were in BRCA1, and 1 (c.4770A>G) was in BRCA2. The mutations were in exon 11, exon 13, intron 16, and exon 20 of BRCA1 and exon 11 of BRCA2. All have been previously reported in different populations. These meta analysis results should be helpful in understanding the possibility of any first true founder mutation of BRCA1/BRCA2 in the Iranian population. In addition, they will be of significance for diagnostic testing, genetic counseling and for epidemiological studies.

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Sep 12, 2000·Human Mutation·I KonstantopoulouD Yannoukakos
Mar 15, 2001·Cancer Letters·A GhaderiH Kimura
Mar 16, 2001·Breast Cancer Research : BCR·D F Easton
Mar 21, 2001·Human Molecular Genetics·P L Welcsh, M C King
May 27, 2005·Journal of Cancer Research and Clinical Oncology·Andrea PietschmannHartmut Peters
Nov 18, 2008·Maturitas·José Antonio Martínez PérezMaite Pérez
Aug 8, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sarah Louise DombernowskyBørge Grønne Nordestgaard
Mar 31, 2010·Breast Cancer Research and Treatment·Brunella PilatoStefania Tommasi
Jul 1, 2010·Asia-Pacific Journal of Public Health·Subhojit Dey, Amr S Soliman
Sep 16, 2011·Familial Cancer·Fatemeh KeshavarziSirous Zeinali
Apr 17, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Afsoon TaghaviMohamad Amin Pourhoseingholi
Jan 16, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Jagadish HansaSankar Kumar Ghosh
Jun 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Hazal HayturalFatmahan Atalar
Sep 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Mohammad Mahdi KooshyarAmirreza Parizadeh
Dec 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Tarique Noorul HasanAli Abdullah Alshatwi
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Abbas RezaianzadehAbdolrasoul Talei
Oct 24, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Mojtaba SepandiAbdolrasoul Talei

❮ Previous
Next ❯

Citations

Oct 6, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Mohammad Forat YazdiHossein Neamatzadeh
Feb 11, 2021·Personalized Medicine·Gholamreza FarnooshMohammad-Reza Mahmoudian-Sani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.